Carbapenemase-Producing Carbapenem-Resistant Enterobacterales Among Children in the United States, 2019-2024
Journal of the Pediatric Infectious Diseases Society · 04.11.2026
DOI: 10.1093/jpids/piag115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 04.11.2026. Verfasst von Danielle A Rankin und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Preventi….
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The current epidemiology of carbapenem-resistant Enterobacterales (CRE) among pediatric patients in the United States is poorly described. We assessed trends in pediatric CRE and carbapenemase-producing-CRE (CP-CRE) incidence in the U.S. and characterized recent pediatric CP-CRE cases.
Methods
We analyzed CRE clinical isolates from patients <18 years submitted to CDC’s Antimicrobial Resistance Laboratory Network from January 2019 through December 2024. Annual unadjusted incidence rates for CRE and CP-CRE were estimated overall and by age group for a national convenience sample and an open cohort of 29 states with required CRE isolate submission. Trends were assessed using Poisson regression. For pediatric patients with incident CP-CRE identified from January 2023 through March 2024, medical chart reviews were performed.
Results
From 2019–2024, the estimated national pediatric CRE and CP-CRE incidence increased 51% (IRR:1.51; 95% CI:1.22, 1.88) and 92% (IRR:1.92; 95% CI:1.25, 2.99), respectively; increases were similar in the open cohort. Infants had the highest incidence rates. Overall, NDM-CRE incidence increased (IRR: 4.24; 95% CI: 2.07, 9.16), surpassing KPC-CRE as the most prominent carbapenemase. Chart reviews were completed for 109 of 129 pediatric patients with CP-CRE; 14% were in patients without healthcare risk factors. Among patients with healthcare risk factors, 75% had an underlying medical condition; the most common underlying condition among infants and toddlers was cardiovascular disease (64%) and among older children was neurocognitive conditions (49%) and malignancies (41%). Common exposures across all age groups included intensive care unit hospitalization (40%) and healthcare outside the United States (37%).
Conclusions
Pediatric CP-CRE incidence is increasing, driven by NDM-CRE for which there are few treatment options. Most cases occurred among children with serious underlying conditions receiving high-acuity care. Prevention opportunities may include admission screening for patients with prior healthcare exposure outside the United States and strengthening infection prevention practices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
- New York State Department of Health, Albany, New York, United States.
- Wadsworth Center, New York State Department of Health Albany, New York, United States.
- Texas Department of State Health Services, Austin, Texas, United States.
- California Department of Public Health, Richmond, California, United States.
- DC Department of Health, District of Columbia, United States.
ORCID-Profile: Danielle A Rankin, Jessica Leaf, James Baggs
Zitieren
APA
Rankin, D. A., Stahl, A. L., Ali, M., Prestel, C., Khan, M. A., Kogut, S., Nazarian, E., Amin, K., Lopez, K., Ryan, B., Hsiao, L., Mitsunaga, T., Haque, M. S., Johnson, C., Leaf, J., Bailey, C., Young, L., Hamdan, T., Mahmod, Z., …, & Pediatric CRE Investigation Group (2026). Carbapenemase-Producing Carbapenem-Resistant Enterobacterales Among Children in the United States, 2019-2024. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piag115
Vancouver
Rankin DA, Stahl AL, Ali M, Prestel C, Khan MA, Kogut S, et al. Carbapenemase-Producing Carbapenem-Resistant Enterobacterales Among Children in the United States, 2019-2024. Journal of the Pediatric Infectious Diseases Society. 2026. doi:10.1093/jpids/piag115
BibTeX
@article{Rankin2026,
author = {Rankin, Danielle A and Stahl, Anna L and Ali, Mohsin and Prestel, Christopher and Khan, Mohammed A and Kogut, Sarah and Nazarian, Elizabeth and Amin, Kajal and Lopez, Kourtney and Ryan, Brady and Hsiao, Lian and Mitsunaga, Tisha and Haque, Mefruz S and Johnson, Candace and Leaf, Jessica and Bailey, Cherlly and Young, Lauren and Hamdan, Tahani and Mahmod, Zakariya and Ostrowsky, Belinda and Armstrong, Tiana and Sabour, Sarah and Huang, Jennifer Y and Baggs, James and Walters, Maroya Spalding and Pediatric CRE Investigation Group, Pediatric CRE Investigation Group},
title = {Carbapenemase-Producing Carbapenem-Resistant Enterobacterales Among Children in the United States, 2019-2024},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2026},
doi = {10.1093/jpids/piag115}
}
EUVIMED